```TEXT

New Retatrutide & Durolane: A Combined Treatment Strategy? Emerging data show a possible synergy between New Retat, a unique dual agonist for glucagon-like peptide-1, and Duro, a hyaluron material infusion. While Retatru targets sugar dysregulation and fat regulation, Duro provides join